FDA Clearance Tracker · P240044-S001
Globe® Catheter and Globe® Pulsed Field System
Last checked: Nov 20, 2026Latest source record: Jun 23, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jun 23, 2026
Approved
Time to decision
267 days
Received Sep 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P240044-S001
- Device name
- Globe® Catheter and Globe® Pulsed Field System
- Applicant
- Kardium, Inc.
- Applicant location
- Burnaby
- Received
- Sep 29, 2025
- Decided
- Jun 23, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P240044
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240044
Source documents
Other decisions for Kardium, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240044 · Decided Aug 27, 2025 · 253 days after receipt
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.